0000000000867390

AUTHOR

Enrique Viosca

showing 3 related works from this author

Allopurinol partially prevents disuse muscle atrophy in mice and humans

2018

AbstractDisuse muscle wasting will likely affect everyone in his or her lifetime in response to pathologies such as joint immobilization, inactivity or bed rest. There are no good therapies to treat it. We previously found that allopurinol, a drug widely used to treat gout, protects muscle damage after exhaustive exercise and results in functional gains in old individuals. Thus, we decided to test its effect in the prevention of soleus muscle atrophy after two weeks of hindlimb unloading in mice, and lower leg immobilization following ankle sprain in humans (EudraCT: 2011-003541-17). Our results show that allopurinol partially protects against muscle atrophy in both mice and humans. The pro…

0301 basic medicineProteasome Endopeptidase Complexmedicine.medical_specialtyScience[SDV]Life Sciences [q-bio]Allopurinolmedicine.medical_treatmentAllopurinolHindlimbBed restArticleMice03 medical and health sciences0302 clinical medicineAtrophyPhysical Conditioning AnimalInternal medicineAnimalsHumansMedicineAnkle InjuriesMuscle SkeletalWastingSoleus muscleMultidisciplinaryUbiquitinbusiness.industryQRmedicine.diseaseMuscular Disorders AtrophicMuscle atrophy3. Good healthGoutMuscular Atrophy030104 developmental biologyEndocrinologyHindlimb SuspensionMedicinemedicine.symptombusiness030217 neurology & neurosurgerymedicine.drugScientific Reports
researchProduct

Alopurinol y su papel en el tratamiento de la sarcopenia

2014

Resumen La xantina oxidasa (XO) es la enzima que cataliza la oxidacion de hipoxantina a xantina y de esta a acido urico, por lo que desempena un importante papel en el catabolismo de las purinas. El alopurinol, un analogo de las purinas, es un conocido inhibidor de la XO ampliamente utilizado en la practica clinica para el tratamiento de la gota. Estudios recientes indican que el alopurinol reduce el estres oxidativo y mejora la funcion vascular en diversas enfemedades cardiometabolicas, aumenta el tiempo de ejercicio en pacientes con angina de pecho y mejora la eficiencia de la contractilidad miocardica en la insuficiencia cardiaca. La XO tambien ejerce un papel importante en la generacion…

AgingMedicine (miscellaneous)Geriatrics and GerontologyRevista Española de Geriatría y Gerontología
researchProduct

Functional Data Analysis for Gait Analysis after Stroke

2013

Variability is one of the key determinants of gait after stroke. Functional Data Analysis (FDA) is a suitable tool to deal with variability associated with movement analysis patterns. In this contribution (FDA) has been applied for the analysis 53 post-stroke patients. Functional Principal Components Analysis (FPCA) has been applied. Dependence of velocity on the functional state of the patient has been found as well as other mechanisms that are hidden in conventional parametric analysis of the curves.

Movement analysismedicine.medical_specialtyPhysical medicine and rehabilitationGait (human)Parametric analysisComputer scienceGait analysisHorizontal forcePrincipal component analysismedicineFunctional data analysismedicine.diseaseStroke
researchProduct